Erdheim-Chester disease requires extensive prospective and thorough work-up for multisystem involvement

Available online 28 March 2024, 107638

Author links open overlay panelSection snippetsEthical approval

not applicable

Consent to participation

not applicable

Consent for publication

not applicable

Funding

none received

Availability of data and material

all data are available from the corresponding author

Author contribution

JF was responsible for the design and conception, discussed available data with coauthors, wrote the first draft, and gave final approval. SM: contributed to literature search, discussion, correction, and final approval

CRediT authorship contribution statement

Josef Finsterer: Data curation, Formal analysis, Writing – original draft, Writing – review & editing.

Declaration of competing interest

the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgements

none

References (8)S Dai et al.Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen

Cardiovasc Pathol

(2024)

M Yoon et al.Erdheim-Chester disease presenting as an intracardiac mass and pericardial effusion confirmed by biopsy: a case report

Eur Heart J Case Rep

(2021)

A Palmisano et al.Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction

Radiol Med

(2023)

C Campochiaro et al.Myocarditis as a manifestation of Erdheim-Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy